- Home
- NBB vs SOPH Comparison
NBB vs SOPH Comparison
Compare NBB & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBB | SOPH |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.2M | 462.3M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NBB | SOPH |
|---|---|---|
| Price | $15.56 | $8.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 64.0K | ★ 529.7K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.95 | $3.10 |
| 52 Week High | $16.62 | $8.98 |
Technical Indicators
Market Signals| Indicator | NBB | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 48.88 | 56.61 |
| Support Level | $15.03 | $4.57 |
| Resistance Level | $15.56 | $8.98 |
| Average True Range (ATR) | 0.17 | 0.50 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 49.52 | 44.30 |
Price Performance
Historical ComparisonAbout NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund has single operating segment.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.